This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Assistance Publique-Hopitaux De Paris, Fondation Imagine - Institut Des Maladies Genetiques, National Institute of Health and Medical Research. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 332 
1 out of 4 
1 out of 1,853 
Years Active: 2024
Title: Emmanuelle Six: Innovator in T-cell Progenitor Generation
Introduction
Emmanuelle Six, based in Saint Geneviève des Bois, France, is a notable inventor in the field of cell therapy. He has made significant contributions to medical science through his innovative work on T-cell progenitors. With one patent to his name, Emmanuelle is carving a niche for himself in the biopharmaceutical industry.
Latest Patents
Emmanuelle Six holds a patent titled "Method for Generating T-cell Progenitors." This invention focuses on an in vitro approach for producing T-cell progenitors. The innovative process involves exposing CD34+ cells to a medium that contains a Notch ligand, specifically a soluble domain of the Delta-like ligand 4 linked to an Fc region of an IgG protein. This method also incorporates a fragment of fibronectin containing the RGDS and CS-1 motifs, along with a heparin-binding domain. Such advancements could have a profound impact on cell therapy techniques.
Career Highlights
Emmanuelle has an impressive career with substantial experience in renowned organizations. He has worked at Assistance Publique-Hôpitaux de Paris, where he likely contributed to various medical research initiatives. Additionally, he has been affiliated with Fondation Imagine - Institut Des Maladies Génétique, furthering research in genetic diseases and therapies.
Collaborations
Throughout his career, Emmanuelle has collaborated with esteemed colleagues, including Marina Cavazzana and Isabelle André. These collaborations are essential in driving forward the research and innovation in the field of cell therapy, showcasing the importance of teamwork in scientific advancements.
Conclusion
Emmanuelle Six stands out as an influential inventor in the advanced field of T-cell progenitor generation. His patent represents a vital contribution to cell therapy, which could revolutionize treatment options for patients. With valuable experience from prestigious institutions and collaboration with notable colleagues, Emmanuelle continues to push the boundaries of medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile